These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28627450)
1. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening. Pérez-Báez W; García-Latorre EA; Maldonado-Martínez HA; Coronado-Martínez I; Flores-García L; Taja-Chayeb L Mol Cell Probes; 2017 Oct; 35():34-43. PubMed ID: 28627450 [TBL] [Abstract][Full Text] [Related]
2. KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencing. Akiyoshi K; Yamada Y; Honma Y; Iwasa S; Kato K; Hamaguchi T; Shimada Y; Taniguchi H; Furuta K Anticancer Res; 2013 May; 33(5):2129-34. PubMed ID: 23645765 [TBL] [Abstract][Full Text] [Related]
3. KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer. Malapelle U; Carlomagno C; Salatiello M; De Stefano A; De Luca C; Bianco R; Marciano R; Cimminiello C; Bellevicine C; De Placido S; Troncone G Br J Cancer; 2012 Aug; 107(4):626-31. PubMed ID: 22805329 [TBL] [Abstract][Full Text] [Related]
4. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms. Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129 [TBL] [Abstract][Full Text] [Related]
5. Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples. Weyn C; Van Raemdonck S; Dendooven R; Maes V; Zwaenepoel K; Lambin S; Pauwels P BMC Cancer; 2017 Feb; 17(1):139. PubMed ID: 28201998 [TBL] [Abstract][Full Text] [Related]
6. Detection of Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617 [TBL] [Abstract][Full Text] [Related]
7. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase. Do H; Dobrovic A Oncotarget; 2012 May; 3(5):546-58. PubMed ID: 22643842 [TBL] [Abstract][Full Text] [Related]
8. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues. Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585 [TBL] [Abstract][Full Text] [Related]
9. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay. Chang YS; Er TK; Lu HC; Yeh KT; Chang JG Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805 [TBL] [Abstract][Full Text] [Related]
10. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR. Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641 [TBL] [Abstract][Full Text] [Related]
11. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer. Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213 [TBL] [Abstract][Full Text] [Related]
12. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR. Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035 [TBL] [Abstract][Full Text] [Related]
13. KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues. Solassol J; Ramos J; Crapez E; Saifi M; Mangé A; Vianès E; Lamy PJ; Costes V; Maudelonde T Int J Mol Sci; 2011; 12(5):3191-204. PubMed ID: 21686179 [TBL] [Abstract][Full Text] [Related]
14. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas. Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679 [TBL] [Abstract][Full Text] [Related]
15. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA. Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762 [TBL] [Abstract][Full Text] [Related]
16. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. Simi L; Pratesi N; Vignoli M; Sestini R; Cianchi F; Valanzano R; Nobili S; Mini E; Pazzagli M; Orlando C Am J Clin Pathol; 2008 Aug; 130(2):247-53. PubMed ID: 18628094 [TBL] [Abstract][Full Text] [Related]
17. Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens. Laosinchai-Wolf W; Ye F; Tran V; Yang Z; White R; Bloom K; Choppa P; Labourier E J Clin Pathol; 2011 Jan; 64(1):30-6. PubMed ID: 21030527 [TBL] [Abstract][Full Text] [Related]